About Atrial Fibrillation Research
Atrial fibrillation (AFib) is a common heart rhythm disorder that affects the atria, the upper chambers of the heart. It can cause irregular and often rapid heartbeats, leading to symptoms like palpitations, shortness of breath, and fatigue. AFib can increase the risk of stroke and other heart-related complications. While there are treatments available to manage AFib and reduce the risk of complications, the condition can still pose challenges for individuals. This highlights the significance of ongoing research in the field of atrial fibrillation. By investigating AFib, scientists aim to better understand its causes, mechanisms, and develop more effective treatments.
Why Participate
You can help advance medicine by joining a clinical trial at Velocity, and you may also:
- Learn about potential new medicines in development
- Get study-related medical exams at no cost
- Receive compensation for participating (available amounts may differ for each study)
After you submit your information, a Velocity enrollment specialist will contact you. Together, we’ll review studies that might be right for you and answer your questions.
Health insurance is NOT required to join. There is never an obligation to participate — we’re here to help you make the best decision.
For more information about currently enrolling research studies, complete the form on this page or select a location below to get in touch with a Velocity enrollment specialist.
